Paper3928010
Modification of blood pressure and nictitating membrane response to sympathetic amines by selective monoamine oxidase inhibitors, types A and B, in the cat.
Finberg JP and 1 other. Br J Pharmacol, 1985. Cited by 35 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Modification of blood pressure and nictitating membrane response to sympathetic amines by selective monoamine oxidase inhibitors, types A and B, in the cat. Papers, record 3928010. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3928010
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Modification of blood pressure and nictitating membrane response to sympathetic amines by selective monoamine oxidase inhibitors, types A and B, in the cat.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amines | Major topic |
| Blood Pressure | Major topic |
| Monoamine Oxidase Inhibitors | Major topic |
| Nictitating Membrane | Major topic |
| Sympathetic Nervous System | Major topic |
| Animals | |
| Brain | |
| Cats | |
| Clorgyline | |
| Female | |
| Indans | |
| Liver | |
| Male | |
| Phenethylamines | |
| Selegiline | |
| Tyramine |
Source PubMed
References19
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 5,550,080 | Occurrence and properties of monoamine oxidase in adrenergic neurons. | J Neurochem | 1971 | https://conductscience.org/library/papers/5550080 | PubMed |
| 2 | 6,418,254 | Tyramine-induced noradrenaline release from rat brain slices: prevention by (-)-deprenyl. | Br J Pharmacol | 1983 | https://conductscience.org/library/papers/6418254 | PubMed |
| 3 | 5,054,207 | Multiple forms of monoamine oxidase in intact mitochondria as characterized by selective inhibitors and thermal stability: a comparison of eight mammalian species. | Adv Biochem Psychopharmacol | 1972 | https://conductscience.org/library/papers/5054207 | PubMed |
| 4 | 5,066,229 | Some puzzling pharmacological effects of monoamine oxidase inhibitors. | Adv Biochem Psychopharmacol | 1972 | https://conductscience.org/library/papers/5066229 | PubMed |
| 5 | 4,788,203 | Monoamine oxidase in rat arteries: evidence for different forms and selective localization. | Br J Pharmacol | 1973 | https://conductscience.org/library/papers/4788203 | PubMed |
| 6 | 1,203,627 | Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration. | Br J Pharmacol | 1975 | https://conductscience.org/library/papers/1203627 | PubMed |
| 7 | 65,560 | Implications of combined treatment with 'Madopar' and L-deprenil in Parkinson's disease. A long-term study. | Lancet | 1977 | https://conductscience.org/library/papers/65560 | PubMed |
| 8 | 66,583 | Varicose veins in tropical Africa. | Lancet | 1977 | https://conductscience.org/library/papers/66583 | PubMed |
| 9 | 96,466 | Deprenyl administration in man: a selective monoamine oxidase B inhibitor without the 'cheese effect'. | Psychopharmacology (Berl) | 1978 | https://conductscience.org/library/papers/96466 | PubMed |
| 10 | 697,901 | Evidence that deprenyl, A type B monoamine oxidase inhibitor, is an indirectly acting sympathomimetic amine. | Biochem Pharmacol | 1978 | https://conductscience.org/library/papers/697901 | PubMed |
| 11 | 745,011 | The possible mechanisms of action of (-)deprenyl in Parkinson's disease. | J Neural Transm | 1978 | https://conductscience.org/library/papers/745011 | PubMed |
| 12 | 745,013 | Absence of "cheese effect" during deprenyl therapy: some recent studies. | J Neural Transm | 1978 | https://conductscience.org/library/papers/745013 | PubMed |
| 13 | 497,571 | Effects of monoamine oxidase inhibitor (MAOI) pretreatment on the fate of intraduodenally instilled [14C]-tyramine [proceedings]. | Br J Pharmacol | 1979 | https://conductscience.org/library/papers/497571 | PubMed |
| 14 | 7,284,698 | Selective acetylenic 'suicide' and reversible inhibitors of monoamine oxidase types A and B. | Br J Pharmacol | 1981 | https://conductscience.org/library/papers/7284698 | PubMed |
| 15 | 6,793,119 | Tyramine antagonistic properties of AGN 1135, an irreversible inhibitor of monoamine oxidase type B. | Br J Pharmacol | 1981 | https://conductscience.org/library/papers/6793119 | PubMed |
| 16 | 7,326,042 | Concentration dependence of the oxidation of tyramine by the two forms of rat liver mitochondrial monoamine oxidase. | Biochem Pharmacol | 1981 | https://conductscience.org/library/papers/7326042 | PubMed |
| 17 | 7,057,191 | Deamination of 5-hydroxytryptamine by both forms of monoamine oxidase in the rat brain. | J Neurochem | 1982 | https://conductscience.org/library/papers/7057191 | PubMed |
| 18 | 6,652,339 | In vivo, noradrenaline is a substrate for rat brain monoamine oxidase A and B. | Br J Pharmacol | 1983 | https://conductscience.org/library/papers/6652339 | PubMed |
| 19 | 4,943,186 | Interactions between sympathomimetic amines and a new monoamine oxidase inhibitor. | Psychopharmacologia | 1970 | https://conductscience.org/library/papers/4943186 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37,047,416 | Sex Difference in Cardioprotection against Acute Myocardial Infarction in MAO-B Knockout Mice In Vivo. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37047416 | PubMed |
| 31,974,721 | The discovery and development of rasagiline as a new anti-Parkinson medication. | J Neural Transm (Vienna) | 2020 | https://conductscience.org/library/papers/31974721 | PubMed |
| 24,011,391 | Monoamine oxidase-B (MAO-B) inhibitors: implications for disease-modification in Parkinson's disease. | Transl Neurodegener | 2013 | https://conductscience.org/library/papers/24011391 | PubMed |
| 22,872,464 | Pressor response to oral tyramine and monoamine oxidase inhibition during treatment with ralfinamide (NW-1029). | Neurotox Res | 2013 | https://conductscience.org/library/papers/22872464 | PubMed |
| 21,850,574 | Pressor response to oral tyramine during co-administration with safinamide in healthy volunteers. | Naunyn Schmiedebergs Arch Pharmacol | 2011 | https://conductscience.org/library/papers/21850574 | PubMed |
| 20,517,484 | The role of rasagiline in the treatment of Parkinson's disease. | Clin Interv Aging | 2010 | https://conductscience.org/library/papers/20517484 | PubMed |
| 19,396,396 | Genomic and proteomic study to survey the mechanism of action of the anti-Parkinson's disease drug, rasagiline compared with selegiline, in the rat midbrain. | J Neural Transm (Vienna) | 2009 | https://conductscience.org/library/papers/19396396 | PubMed |
| 18,072,817 | Spotlight on rasagiline in Parkinson's disease. | CNS Drugs | 2008 | https://conductscience.org/library/papers/18072817 | PubMed |
| 17,683,172 | Rasagiline: a review of its use in the management of Parkinson's disease. | Drugs | 2007 | https://conductscience.org/library/papers/17683172 | PubMed |
| 16,402,116 | Monoamine oxidase: isoforms and inhibitors in Parkinson's disease and depressive illness. | Br J Pharmacol | 2006 | https://conductscience.org/library/papers/16402116 | PubMed |
| 12,043,833 | Molecular basis of neuroprotective activities of rasagiline and the anti-Alzheimer drug TV3326 [(N-propargyl-(3R)aminoindan-5-YL)-ethyl methyl carbamate]. | Cell Mol Neurobiol | 2001 | https://conductscience.org/library/papers/12043833 | PubMed |
| 11,159,700 | Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B. | Br J Pharmacol | 2001 | https://conductscience.org/library/papers/11159700 | PubMed |
| 8,390,270 | Dopamine metabolism and neurotransmission in primate brain in relationship to monoamine oxidase A and B inhibition. | J Neural Transm Gen Sect | 1993 | https://conductscience.org/library/papers/8390270 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| MAOA | 4,128 | PubTator's text mining | https://conductscience.org/library/genes/4128 | NCBI Gene |
| MAOB | 4,129 | PubTator's text mining | https://conductscience.org/library/genes/4129 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3928010
GET https://conductscience.org/api/papers/v1/3928010/authors